Elimination of Causative Antibody by Plasma Exchange in a Patient with an Acute Hemolytic Transfusion Reaction.
10.17945/kjbt.2018.29.1.79
- Author:
Namsu KIM
1
;
Jaehyeon LEE
;
Dal Sik KIM
;
Hye Soo LEE
;
Sam Im CHOI
;
Yong Gon CHO
Author Information
1. Department of Laboratory Medicine, Chonbuk National University Medical School, Jeonju, Korea. choyg@jbnu.ac.kr
- Publication Type:Case Report
- Keywords:
ABO incompatible transfusion;
Plasma exchange;
Acute hemolytic transfusion reaction
- MeSH:
Clergy;
Consensus;
Diuretics;
Emergencies;
Emergency Service, Hospital;
Hematuria;
Hemorrhage;
Humans;
Hypotension;
Lacerations;
Male;
Multiple Trauma;
Neck;
Plasma Exchange*;
Plasma*;
Prognosis;
Transfusion Reaction*
- From:Korean Journal of Blood Transfusion
2018;29(1):79-85
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
An ABO-incompatible transfusion is a very rare event but it can cause severe adverse effects, including death. The prognosis is affected by various factors, such as the volume of infusion, underlying diseases, and immunologic state. Until now, however, there has been no consensus regarding the treatment of an ABO-incompatible transfusion except for conservative treatment. A 57 year-old male patient visited the authors' emergency unit with multiple trauma due to a car accident. He had a deep laceration on his left neck accompanied by severe bleeding. Because of his low blood pressure and low hemoglobin level due to bleeding, an emergency transfusion was attempted. Unfortunately, one unit of RBC was transfused incorrectly into the patient due to a clerical error during the identification of the patient. The patient was typed as O, RhD positive; the RBC administered was A, RhD positive. After the transfusion, the patient showed an acute hemolytic transfusion reaction due to gross hematuria. Plasma exchange was attempted and medical treatment with high dose steroid with diuretics was done simultaneously. Two cycles of plasma exchange were done and the patient appeared to recover from the acute adverse effects of the transfusion. The plasma exchange was stopped and medical treatments for the transfusion reactions were maintained for ten days. The patient recovered fully and was discharged after one month. Based on this case, although more studies are necessary for approval as a standard therapy, this case suggests that immediate plasma exchange with medical treatment can be very helpful for eliminating the isoagglutinins in ABO-incompatible transfusions.
